| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 250mg | |||
| Other Sizes |
| Targets |
There is no specific molecular target reported for MNP-Glc. It functions as a general biochemical reagent, potentially acting as a sulfonylation reagent for organic synthesis and drug discovery.
|
|---|---|
| ln Vitro |
There is no specific in vitro activity data available for this compound. As a biochemical reagent, its activity is typically defined by its purity and performance in standard chemical reactions, such as acting as a substrate or intermediate in organic synthesis.
|
| ln Vivo |
A specific in vivo activity has not been reported for MNP-Glc. It is classified as a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research, and is not intended for therapeutic in vivo applications.
|
| Enzyme Assay |
There is no specific enzyme/receptor binding protocol for this compound. A typical protocol for using MNP-Glc in organic synthesis involves dissolving the compound in an appropriate solvent (e.g., DMF or DMSO) to a desired concentration (e.g., 0.1-1 M) and reacting it with a nucleophile under basic or acidic conditions, with reaction progress monitored by TLC or HPLC.
|
| Cell Assay |
There is no specific cell-based protocol for this compound. MNP-Glc is typically utilized as a biochemical reagent rather than a cellular probe. If used in cell culture, a general protocol would involve dissolving the reagent in DMSO to a stock concentration of 10-50 mM, then diluting it to working concentrations (e.g., 1-100 uM) in cell culture medium for specified incubation times.
|
| Animal Protocol |
There is no standard in vivo animal protocol for this compound. As a general biochemical reagent, it is not intended for use in live animals.
|
| ADME/Pharmacokinetics |
General PK properties for this small molecule are not applicable, as it is not used as a drug. Its stability is typical for a glucoside, and it is likely soluble in polar organic solvents. Formulation is commonly in DMSO for experimental use.
|
| Toxicity/Toxicokinetics |
General toxicity for this biochemical reagent is considered low. At working concentrations (uM to mM range), no significant cytotoxicity has been reported. Standard safety precautions for handling laboratory chemicals should be observed.
|
| Additional Infomation |
MNP-Glc is a research-grade biochemical reagent intended for laboratory use only. It is available in high purity (typically ≥95%) and is used as a building block in organic synthesis or as a sulfonylation reagent. This product is not for diagnostic or therapeutic use in humans.
|
| Molecular Formula |
C15H19NO9
|
|---|---|
| Molecular Weight |
357.31
|
| Exact Mass |
357.106
|
| CAS # |
70622-80-9
|
| Appearance |
Typically exists as solid at room temperature
|
| SMILES |
C1(=CC(=CC=C1OC)/C=C/[N+]([O-])=O)O[C@H]1[C@H](O)[C@H]([C@H](O)[C@@H](CO)O1)O
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7987 mL | 13.9935 mL | 27.9869 mL | |
| 5 mM | 0.5597 mL | 2.7987 mL | 5.5974 mL | |
| 10 mM | 0.2799 mL | 1.3993 mL | 2.7987 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
